Optimising medicines use in older adults with intellectual disability who have epilepsy: challenges and perspectives.

O'Dwyer, Maire; Watkins, Lance; McCallion, Philip; McCarron, Mary; Henman, Martin; Shankar, Rohit

O'Dwyer, Maire; Watkins, Lance; McCallion, Philip; McCarron, Mary; Henman, Martin; Shankar, Rohit.

Afiliação

O'Dwyer M; School of Pharmacy and Pharmaceutical Sciences, University of Dublin Trinity College, Dublin, 2, Ireland.
Watkins L; Swansea Bay University Health Board Ringgold Standard Institution, Neath Port Talbot, UK.
McCallion P; School of Social Work, College of Public Health, Temple University, Philadelphia, PA, USA.
McCarron M; Trinity Centre for Ageing and Intellectual Disability, School of Nursing and Midwifery, University of Dublin, Trinity College Dublin, Ireland.
Henman M; School of Pharmacy and Pharmaceutical Sciences, University of Dublin Trinity College, Dublin, Ireland.
Shankar R; Cornwall Partnership NHS Foundation Trust, Threemilestone Industrial Estate, Truro, UK, and Exeter Medical School, Knowledge Spa, Royal Cornwall Hospital, Truro, UK.

Ther Adv Drug Saf ; 12: 20420986211025157, 2021.

Article em En | MEDLINE | ID: mdl-34394909

Palavras-chave

anti-seizure drugs; epilepsy; intellectual disability; polypharmacy; seizures

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ther Adv Drug Saf Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irlanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google